Anti-SARS-CoV-2 antibodies in new-onset type 1 diabetes in children during pandemic in Belgium.

Anissa MessaaouiLucia HajselovaSylvie Tenoutasse

Published in: Journal of pediatric endocrinology & metabolism : JPEM (2021)

The prevalence of anti-SARS-CoV-2 antibodies in children with newly diagnosed type 1 diabetes (20%) is similar to that found in children without diabetes in Belgium, a country severely affected by this pandemic.

Keyphrases

sars cov
type diabetes
young adults
respiratory syndrome coronavirus
newly diagnosed
glycemic control
coronavirus disease
risk factors
insulin resistance
metabolic syndrome
adipose tissue